Kestra Advisory Services’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Kestra Advisory Services’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-430	Closed	-$8K	–	2385
2022 Q3	$8K	Hold	430	–	–	﹤0.01%	2086
2022 Q2	$22K	Hold	430	–	–	﹤0.01%	2084
2022 Q1	$61K	Hold	430	–	–	﹤0.01%	1957
2021 Q4	$73K	Buy	+430	New	+$160K	﹤0.01%	1960
2021 Q1	–	Sell	-158	Closed	-$70K	–	2103
2020 Q4	$70K	Buy	158 +123	+351%	+$40.4K	﹤0.01%	1802
2020 Q3	$10K	Buy	+35	New	+$8.68K	﹤0.01%	1410

Other funds holding AMPE

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ARG

Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Kestra Advisory Services's AMPE Position: Q4 2022 in Review

Kestra Advisory Services sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 430 shares — an estimated $8K sold.

Kestra Advisory Services first reported a position in AMPE in Q3 2020 and held it in 6 quarters. The position peaked at $73K in Q4 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

Kestra Advisory Services reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
Kestra Advisory Services sold 430 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $8K.
Kestra Advisory Services first reported a position in Ampio Pharmaceuticals Inc. in Q3 2020 and held it in 6 quarters.
Kestra Advisory Services's Ampio Pharmaceuticals Inc. position peaked at $73K in Q4 2021.
32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Kestra Advisory Services's 13F filing for Q4 2022, filed 31 Jan 2023.